17 May 2021 : Clinical Research
Immunogenicity of Split Inactivated Quadrivalent Influenza Vaccine in Adults with Obesity in the 2017/2018 Season
Anna M. Jagielska


DOI: 10.12659/MSM.929572
Med Sci Monit 2021; 27:e929572
Table 3 Parameters of vaccine immunogenicity (N=53).
Antibodies | GMT | MFI | PR (%) | RR (%) | ||
---|---|---|---|---|---|---|
Pre | Post | Pre | Post | |||
A/Michigan/45/2015 (A/H1N1/pdm09)-like strain | 1.98 | 59.44* | 42.2 | 11.3 | 77.4* | 84.9 |
A/Hong Kong/4801/2014 (A/H3N2/)-like strain | 1.55 | 73.38* | 47.3 | 3.8 | 83.0* | 86.8 |
B/Brisbane/60/2008-like strain (Victoria lineage) | 11.87 | 166.53* | 14.0 | 30.2 | 96.2* | 88.7 |
B/Phuket/3073/2013-like strain (Yamagata lineage) | 34.82 | 129.25* | 3.7 | 83.0 | 96.2* | 66.0 |
Pre – pre-vaccination; Post – post-vaccination; GMT – Geometric Mean antibody Titers; MFI – mean fold increase; PR – protection rate; RR – response rate. * p |